Complementary appearance of glucose and lipid metabolism in cardiac sarcoidosis

Cardiac sarcoidosis complicated with atrioventricular block and wall thinning, edema and fibrosis in left ventricle: Confirmed recovery to normal sinus rhythm and visualization of edema improvement by administration of predonisolone

“…Interstitial change in LV myocardium can be evaluated by CT to indicate early defects and late enhancement in subjects with old myocardial infarction [6], hypertrophic cardiomyopathy [7][8][9], cardiac amyloidosis [9], and acute myocarditis [10]; such change can also be evaluated by MRI to indicate late enhancement in T1 weighted images in subjects with old myocardial infarction [11][12][13], hypertrophic and dilated cardiomyopathy [14][15][16]. However, reliance on such images makes differentiation of edema from fibrosis on the basis of interstitial changes difficult.…”

123I-BMIPP delayed scintigraphic imaging in patients with chronic heart failure

“…The abnormal uptake of cardiac BMIPP is a sensitive marker of severe myocardial damage in patients with ischemic heart diseases [3][4][5], idiopathic dilated cardiomyopathy (DCM) [6][7][8], hypertrophic cardiomyopathy [9,10], and cardiac sarcoidosis [11]. Furthermore, myocardial fatty acid metabolic analysis with BMIPP imaging is an accepted prophylactic tool in strategies to prevent CHF [2,12].…”

Differentiation of diagnosis and prognoses of non-coronary arterial primary myocardial diseases with left ventricular focal myocardial thinning evaluated by multislice computed tomography

“…Until now, diagnosis of cardiac sarcoidosis has been based on the presence of bilateral lymph node swelling in hilum, specific findings in other organs such as eyes, skin, liver, and increment of serum ACE [5,6,[8][9][10][11][12]. Also in cardiac sarcoidosis, thinned sites are commonly in IVS [1][2][3] but sometimes occur at other sites such as the inferior wall.…”